957,045 Shares in Maximus, Inc. (NYSE:MMS) Purchased by Norges Bank

Norges Bank bought a new position in shares of Maximus, Inc. (NYSE:MMS - Free Report) during the 4th quarter, according to its most recent 13F filing with the SEC. The firm bought 957,045 shares of the health services provider's stock, valued at approximately $71,443,000. Norges Bank owned 1.68% of Maximus as of its most recent filing with the SEC.

Other large investors also recently made changes to their positions in the company. UMB Bank n.a. raised its stake in shares of Maximus by 79.8% in the 4th quarter. UMB Bank n.a. now owns 356 shares of the health services provider's stock valued at $27,000 after purchasing an additional 158 shares during the period. Eastern Bank bought a new position in shares of Maximus during the fourth quarter worth about $29,000. V Square Quantitative Management LLC raised its position in Maximus by 65.9% in the 4th quarter. V Square Quantitative Management LLC now owns 453 shares of the health services provider's stock valued at $34,000 after buying an additional 180 shares during the last quarter. R Squared Ltd bought a new stake in Maximus in the 4th quarter valued at approximately $54,000. Finally, IFP Advisors Inc boosted its position in Maximus by 62.4% during the 4th quarter. IFP Advisors Inc now owns 786 shares of the health services provider's stock worth $59,000 after acquiring an additional 302 shares during the last quarter. Institutional investors own 97.21% of the company's stock.

Maximus Stock Down 1.9 %

MMS traded down $1.29 on Monday, hitting $67.36. 697,844 shares of the company were exchanged, compared to its average volume of 541,283. The stock's fifty day moving average is $68.94 and its 200-day moving average is $76.96. Maximus, Inc. has a 12 month low of $63.77 and a 12 month high of $93.97. The company has a debt-to-equity ratio of 0.82, a quick ratio of 1.72 and a current ratio of 1.72. The company has a market cap of $3.81 billion, a PE ratio of 14.49 and a beta of 0.68.

Remove Ads

Maximus (NYSE:MMS - Get Free Report) last announced its quarterly earnings data on Thursday, February 6th. The health services provider reported $1.61 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.39 by $0.22. Maximus had a return on equity of 21.95% and a net margin of 5.28%. Equities research analysts predict that Maximus, Inc. will post 6.15 EPS for the current fiscal year.

Maximus Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Saturday, May 31st. Stockholders of record on Thursday, May 15th will be given a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a dividend yield of 1.78%. Maximus's dividend payout ratio (DPR) is presently 25.81%.

Insider Transactions at Maximus

In other news, Director Jan Madsen sold 2,439 shares of the firm's stock in a transaction that occurred on Tuesday, March 18th. The stock was sold at an average price of $67.71, for a total value of $165,144.69. Following the completion of the sale, the director now directly owns 18,097 shares of the company's stock, valued at $1,225,347.87. This trade represents a 11.88 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, insider Ilene R. Baylinson sold 14,500 shares of the business's stock in a transaction that occurred on Wednesday, February 19th. The stock was sold at an average price of $68.14, for a total value of $988,030.00. Following the transaction, the insider now directly owns 2,512 shares in the company, valued at $171,167.68. The trade was a 85.23 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.60% of the stock is owned by company insiders.

Analyst Ratings Changes

MMS has been the topic of a number of recent research reports. StockNews.com downgraded shares of Maximus from a "buy" rating to a "hold" rating in a report on Friday, February 14th. Raymond James upgraded shares of Maximus from a "market perform" rating to an "outperform" rating and set a $90.00 price target on the stock in a research note on Thursday, January 2nd.

Maximus Company Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.